EUVIMEDEUVIMED entdecken
Open Access

High‐dose ceftriaxone: Pharmacokinetic and pharmacodynamic insights in hospitalized patients with suspected sepsis in Thailand

Nattapat Sangkakul iD, Apinya Boonpeng iD, Pisud Siripaitoon iD, Narongdet Kositpantawong iD, Siripen Kanchanasuwan iD, Sorawit Chittrakarn iD, Monchana Jullangkoon iD, Boonsri Charoenmak, Sarunyou Chusri iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Nattapat Sangkakul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. Hauptthemen laut MEDLINE: Ceftriaxone, Sepsis, Anti-Bacterial Agents, Models, Biological. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Faculty of Medicine, Prince of Songkla University, University of Phayao and Thailand Science Research and Innovation Fund (Fundamental Fund 2025).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Appropriate drug exposure is as crucial as proper selection and timely antibiotic administration in sepsis treatment. However, evidence is lacking regarding the current dosing regimen to achieve pharmacodynamic targets. This study aimed to describe ceftriaxone pharmacokinetic (PK) parameters and establish optimal dosing regimens for sepsis patients.

Methods

This study investigated the pharmacokinetics of ceftriaxone in sepsis patients receiving ceftriaxone 2 g every 12 or 24 h. Blood samples (11–14 samples per patient) were collected within the first 24 h post‐administration. PK parameters were estimated from unbound plasma concentrations using a nonlinear mixed‐effects modelling approach (NONMEM® software). Monte Carlo simulations were conducted to evaluate the probability of target attainment of standard and high‐dose ceftriaxone at various minimum inhibitory concentrations (MICs).

Results

Population PK analysis of 238 concentration–time data points from 20 patients revealed that a two‐compartment model best described ceftriaxone PK. Glomerular filtration rate (GFR), serum albumin, and body weight significantly affected clearance, volume of distribution, and intercompartmental clearance, respectively. Simulation demonstrated that standard dose of 2 g every 24 h was adequate for pathogens with MIC ≤1 mg L −1 . At higher MIC values, target attainment decreased, particularly in with GFR > 130 mL·min −1 , with twice‐daily dosing yielding higher exposures.

Conclusion

Standard ceftriaxone (2 g intravenous q 24 h, 30‐min infusion) provided adequate target attainment at low MICs in this exploratory study of suspected sepsis. PTA decreased with higher MICs and higher renal function, with higher dose regimens showing numerically greater exposures. These findings may help guide future studies on dosing optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftriaxoneSepsisAnti-Bacterial AgentsModels, BiologicalHumansFemaleMaleMiddle AgedMonte Carlo MethodMicrobial Sensitivity TestsAgedThailandAdultGlomerular Filtration RateDose-Response Relationship, DrugThird Generation CephalosporinsDrug Administration ScheduleAged, 80 and overSecond Generation Cephalosporins

Stichwörter der Autor:innen

antibiotic dosingceftriaxonepharmacodynamicspharmacokineticssepsis

Substanzen

CeftriaxoneAnti-Bacterial AgentsThird Generation CephalosporinsSecond Generation Cephalosporins

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Division of Clinical Pharmacy, Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Phayao, Muang District, Phayao, Thailand.

ORCID-Profile: Nattapat Sangkakul, Apinya Boonpeng, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Sorawit Chittrakarn, Monchana Jullangkoon, Sarunyou Chusri

Förderung

  • Faculty of Medicine, Prince of Songkla University
  • University of Phayao and Thailand Science Research and Innovation Fund (Fundamental Fund 2025)

Zitieren

APA

Sangkakul, N., Boonpeng, A., Siripaitoon, P., Kositpantawong, N., Kanchanasuwan, S., Chittrakarn, S., Jullangkoon, M., Charoenmak, B., & Chusri, S. (2026). High‐dose ceftriaxone: Pharmacokinetic and pharmacodynamic insights in hospitalized patients with suspected sepsis in Thailand. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70480

Vancouver

Sangkakul N, Boonpeng A, Siripaitoon P, Kositpantawong N, Kanchanasuwan S, Chittrakarn S, et al. High‐dose ceftriaxone: Pharmacokinetic and pharmacodynamic insights in hospitalized patients with suspected sepsis in Thailand. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70480

BibTeX
@article{Sangkakul2026,
  author = {Sangkakul, Nattapat and Boonpeng, Apinya and Siripaitoon, Pisud and Kositpantawong, Narongdet and Kanchanasuwan, Siripen and Chittrakarn, Sorawit and Jullangkoon, Monchana and Charoenmak, Boonsri and Chusri, Sarunyou},
  title = {High‐dose ceftriaxone: Pharmacokinetic and pharmacodynamic insights in hospitalized patients with suspected sepsis in Thailand},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70480}
}
Kostenlos starten →